Where does Bioptigen, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bioptigen, Inc. ranks #8,338 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bioptigen, Inc. hold?

Bioptigen, Inc. holds 38 US utility patents granted between 2015 and 2023, spanning 13 technology areas.

What is Bioptigen, Inc.'s Innovation Score?

Bioptigen, Inc. has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioptigen, Inc. focus on?

Bioptigen, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 36 patents, ranking #527 of 7,127 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Bioptigen, Inc.'s patent grant rate increasing or decreasing?

Bioptigen, Inc.'s recent grant velocity is -94% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bioptigen, Inc.'s patents?

Bioptigen, Inc.'s patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bioptigen, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bioptigen, Inc.

USPTO PatentsView assignee record - 38 granted patents across 13 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioptigen ranks #8,338 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 13 technology areas.

#8,338
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 14.1
avg claims per patent: -94%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8338 · US Corporation #8,338 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,338/49,997
PHOTO-FINISH Battenfeld
CPC-FOCUS A61B · 13 areas
INNOV-THIN 36.1/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -94% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Battenfeld Technologies, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bioptigen’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (35%) Velocity 2.2 pts (6%) Breadth 12.7 pts (35%) Claim depth 8.5 pts (24%)

Qualcomm Incorporated · highest

85
Hangzhou DAC Biotech · near

36
Bioptigen · this assignee

36
Medrx · near

36
Neofect · near

36
Obschestvo S… · near

36
3D Lighting… · lowest

7

What this shows Bioptigen's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bioptigen?

Each dot is one of Bioptigen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioptigen’s own 14.1 claims/patent is ABOVE the 7.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bioptigen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bioptigen's grants concentrate

Bioptigen, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 94.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2022. By volume, Bioptigen sits between Bway Corporation and China University OF Geosciences (BEIJING).

Bioptigen's three-year grant acceleration

Bioptigen, Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bway

38
Battenfeld

38
Beifa Group

38
Beta-calco

38
Biosynthetic

38
Canadian Tire

38
Champ Tech Optica…

38
China University…

38
Bioptigen ◀

38

What this shows Bioptigen holds 38 patents at rank #8,341, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioptigen

By rank, the assignees closest to #8,341 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bioptigen's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bioptigen, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Bioptigen ranks #527 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Neofect Co., Ltd. 36 Medrx Co., Ltd. 36 Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” 36 Hangzhou DAC Biotech Co., Ltd. 36

Bioptigen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bioptigen, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	18.4%
2016	10	26.3%
2017	7	18.4%
2018	6	15.8%
2019	6	15.8%
2022	1	2.6%
2023	1	2.6%

Which technologies does Bioptigen, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 36

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 18

G02B - Optical Elements, Systems OR Apparatus 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

G06T - Image Data Processing OR Generation, IN General 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

G01P - Measuring Linear OR Angular Speed, Acceleration, Deceleration, OR SHOCK; Indicating Presence, Absence, OR Direction, OF Movement 2

G01M - Testing Static OR Dynamic Balance OF Machines OR STRUCTURES; Testing OF Structures OR Apparatus, NOT Otherwise Provided FOR 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G06V - Image OR Video Recognition OR Understanding 1

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 1

Y10T - Technical Subjects Covered BY Former US Classification 1

F21V - Functional Features OR Details OF Lighting Devices OR Systems THEREOF; Structural Combinations OF Lighting Devices With Other Articles, NOT Otherwise Provided FOR 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bioptigen, Inc.'s patent record in context - here's where to go next.

Bioptigen, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,338 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bioptigen, Inc. against Bway Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.